Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Durden

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 1, 1993
The effect of the MAO-A selective inhibitor brofaromine on the plasma and urine concentrations of some biogenic amines and their acidic metabolites in bulimia nervosaB A Davis, S H Kennedy, D A Durden, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1991
Phenylacetic acid in CSF and serum in Indian schizophrenic patientsB A Davis, S Shrikhande, V P Paralikar, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1991
Effect of dietary phenylalanine on the plasma concentrations of phenylalanine, phenylethylamine and phenylacetic acid in healthy volunteersB A Davis, R L O'Reilly, C L Placatka, et al.
Journal of Neurochemistry|February 1, 1994
Neurochemical and neuroprotective effects of some aliphatic propargylamines: new selective nonamphetamine-like monoamine oxidase B inhibitorsP H Yu, B A Davis, D A Durden, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 1, 1993
A longitudinal study of the relationships between psychometric test scores, offence history and the plasma concentrations of phenylacetic and 5-hydroxyindoleacetic acids in seven inmates of a prison for the psychiatrically disturbedB A Davis, D A Durden, K Pease, et al.
Psychiatry Research|January 1, 1991
Longitudinal study of inmates of a prison for the psychiatrically disturbed: plasma concentrations of biogenic amine metabolites and amino acidsB A Davis, P H Yu, D A Durden, et al.
Advances in Pharmacology (San Diego, Calif.)|November 5, 1997
Aliphatic N-methylpropargylamines: monoamine oxidase-B inhibitors and antiapoptotic drugsA A Boulton, P H Yu, B A Davis, et al.
Neurochemical Research|December 1, 1995
Inhibition of MAO-B by (-)-deprenyl alters dopamine metabolism in the macaque (Macaca facicularis) brainI A Paterson, B A Davis, D A Durden, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1991
Deuterium-labelled p-tyramine challenge test and phenolsulfotransferase activity in depressed patients--failure to replicate decreased p-tyramine conjugation in depressionB A Davis, A A Boulton, P H Yu, et al.
Biological Psychiatry|September 15, 1991
Longitudinal effect of amitriptyline and fluoxetine treatment on plasma phenylacetic acid concentrations in depressionB A Davis, A A Boulton, P H Yu, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 1, 1993
The effect of the MAO-A selective inhibitor brofaromine on the plasma and urine concentrations of some biogenic amines and their acidic metabolites in bulimia nervosaB A Davis, S H Kennedy, D A Durden, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1991
Phenylacetic acid in CSF and serum in Indian schizophrenic patientsB A Davis, S Shrikhande, V P Paralikar, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1991
Effect of dietary phenylalanine on the plasma concentrations of phenylalanine, phenylethylamine and phenylacetic acid in healthy volunteersB A Davis, R L O'Reilly, C L Placatka, et al.
Journal of Neurochemistry|February 1, 1994
Neurochemical and neuroprotective effects of some aliphatic propargylamines: new selective nonamphetamine-like monoamine oxidase B inhibitorsP H Yu, B A Davis, D A Durden, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 1, 1993
A longitudinal study of the relationships between psychometric test scores, offence history and the plasma concentrations of phenylacetic and 5-hydroxyindoleacetic acids in seven inmates of a prison for the psychiatrically disturbedB A Davis, D A Durden, K Pease, et al.
Psychiatry Research|January 1, 1991
Longitudinal study of inmates of a prison for the psychiatrically disturbed: plasma concentrations of biogenic amine metabolites and amino acidsB A Davis, P H Yu, D A Durden, et al.
Advances in Pharmacology (San Diego, Calif.)|November 5, 1997
Aliphatic N-methylpropargylamines: monoamine oxidase-B inhibitors and antiapoptotic drugsA A Boulton, P H Yu, B A Davis, et al.
Neurochemical Research|December 1, 1995
Inhibition of MAO-B by (-)-deprenyl alters dopamine metabolism in the macaque (Macaca facicularis) brainI A Paterson, B A Davis, D A Durden, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1991
Deuterium-labelled p-tyramine challenge test and phenolsulfotransferase activity in depressed patients--failure to replicate decreased p-tyramine conjugation in depressionB A Davis, A A Boulton, P H Yu, et al.
Biological Psychiatry|September 15, 1991
Longitudinal effect of amitriptyline and fluoxetine treatment on plasma phenylacetic acid concentrations in depressionB A Davis, A A Boulton, P H Yu, et al.
Pageof 7